首页> 外文期刊>Breast Cancer Research and Treatment >Bad expression predicts outcome in patients treated with tamoxifen
【24h】

Bad expression predicts outcome in patients treated with tamoxifen

机译:表达不良可预测他莫昔芬治疗的结果

获取原文
获取原文并翻译 | 示例
           

摘要

Activation of the PI3K/Akt signal transduction pathway has been linked to endocrine resistance in tamoxifen treated breast cancer patients. Activation of the PI3K/Akt pathway causes phosphorylation of Bad leading to modulation of cellular apoptosis. The present study was carried out to test the hypothesis that disruption of apoptosis in breast cancer, via Akt activation, is linked with hormone resistance.
机译:PI3K / Akt信号转导途径的激活与他莫昔芬治疗的乳腺癌患者的内分泌抵抗力有关。 PI3K / Akt途径的激活引起Bad的磷酸化,从而导致细胞凋亡的调节。进行本研究以检验假说,即通过Akt激活破坏乳腺癌细胞凋亡与激素抵抗有关。

著录项

  • 来源
    《Breast Cancer Research and Treatment》 |2007年第2期|173-179|共7页
  • 作者单位

    Endocrine Cancer Group Glasgow Royal Infirmary University Department of Surgery Glasgow G31 2ER Scotland UK;

    Endocrine Cancer Group Glasgow Royal Infirmary University Department of Surgery Glasgow G31 2ER Scotland UK;

    Endocrine Cancer Group Glasgow Royal Infirmary University Department of Surgery Glasgow G31 2ER Scotland UK;

    Glasgow Royal Infirmary University Department of Pathology Glasgow G31 2ER Scotland UK;

    Endocrine Cancer Group Glasgow Royal Infirmary University Department of Surgery Glasgow G31 2ER Scotland UK;

    Endocrine Cancer Group Glasgow Royal Infirmary University Department of Surgery Glasgow G31 2ER Scotland UK;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Apoptosis; Bad; pBad (ser 112); Bax; Bcl-2; Bcl-xl;

    机译:凋亡;坏;pBad(ser 112);Bax;Bcl-2;Bcl-xl;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号